Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genvoya and Darunavir PK for HIV PEP
NCT03472963Phase 1Completed
- Sponsor
- Emory University
- Start
- Apr 2018
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of tenofovir alafenamide and darunavir in human immunodeficiency virus infection (HIV), sponsored by Emory University. Started Apr 2018; status: completed.
02
Drugs
tenofovir alafenamidedarunavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03472963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03472963.